We've found
184,457
clinical trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling,
Phase
II
Updated: 10/28/2015
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling,
Phase
II
Updated: 3/31/2016
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling,
Phase
II
Updated: 3/31/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Symptom Management for Irritable Bowel Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Status: Enrolling,
Phase
II
Updated: 3/21/2017
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 11/4/2015
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Nonconvulsive Seizures Clinical Trial
Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Oncology Clinical Trial
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
Status: Enrolling,
Phase
I
Updated: 7/28/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling
Status: Enrolling,
Phase
Updated: 11/16/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM
Status: Enrolling,
Phase
I, II
Updated: 12/12/2016
Click here to add this to my saved trials
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas Clinical Trial
A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Clinical Trial
Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
Cancer Clinical Trial
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D Deficiency Clinical Trial
Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Gastroenteritis Clinical Trial
A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 1/8/2015
Click here to add this to my saved trials
Blood Transfusion Complications Clinical Trial
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
NAC to Prevent Cisplatin-induced Hearing Loss
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Autism Clinical Trial
Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium
Status: Enrolling,
Phase
II
Updated: 7/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Status: Enrolling
Updated: 2/20/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Status: Enrolling
Updated: 2/20/2015
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Multiple Myeloma in Relapse Clinical Trial
Updated: 12/31/1969
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/28/2015
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling,
Phase
II
Updated: 10/28/2015
Click here to add this to my saved trials
Anemia Clinical Trial
Updated: 3/31/2016
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling,
Phase
II
Updated: 3/31/2016
Click here to add this to my saved trials
Anemia Clinical Trial
Updated: 3/31/2016
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling,
Phase
II
Updated: 3/31/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Symptom Management for Irritable Bowel Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
Updated: 12/31/1969
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 3/21/2017
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Status: Enrolling,
Phase
II
Updated: 3/21/2017
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Updated: 11/4/2015
A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 11/4/2015
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Updated: 12/31/1969
A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 10/7/2015
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Updated: 12/31/1969
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 1/31/2018
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 1/31/2018
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Updated: 1/31/2018
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Click here to add this to my saved trials
Nonconvulsive Seizures Clinical Trial
Updated: 2/6/2018
Nonconvulsive Seizure Identification on Quantitative EEG by Neuro ICU Nurses
Status: Enrolling
Updated: 2/6/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/28/2016
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
Status: Enrolling,
Phase
I
Updated: 7/28/2016
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Updated: 11/16/2015
Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling
Status: Enrolling,
Phase
Updated: 11/16/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 2/5/2018
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Glioblastoma Clinical Trial
Updated: 12/12/2016
Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM
Status: Enrolling,
Phase
I, II
Updated: 12/12/2016
Click here to add this to my saved trials
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas Clinical Trial
Updated: 12/31/1969
A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Updated: 12/31/1969
PERIGON Pivotal Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Healthy Clinical Trial
Updated: 10/26/2015
Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
Status: Enrolling
Updated: 10/26/2015
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D Deficiency Clinical Trial
Updated: 12/31/1969
Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune Function
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
Updated: 12/31/1969
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Gastroenteritis Clinical Trial
Updated: 7/10/2015
A Multi-Site Clinical Evaluation of the ARIES Norovirus Assay
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Updated: 12/31/1969
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
Updated: 1/8/2015
A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 1/8/2015
Click here to add this to my saved trials
Blood Transfusion Complications Clinical Trial
Updated: 12/31/1969
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
NAC to Prevent Cisplatin-induced Hearing Loss
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Autism Clinical Trial
Updated: 7/25/2016
Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium
Status: Enrolling,
Phase
II
Updated: 7/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 2/20/2015
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Status: Enrolling
Updated: 2/20/2015
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Updated: 2/20/2015
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Status: Enrolling
Updated: 2/20/2015
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials